e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitors
…, PA Renhowe, TG Gesner, JM Jansen, J Lin…
Index: McBride, Christopher M.; Renhowe, Paul A.; Gesner, Thomas G.; Jansen, Johanna M.; Lin, Julie; Ma, Sylvia; Zhou, Yasheen; Shafer, Cynthia M. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 14 p. 3789 - 3792
The 3-benzimidazol-2-yl-1H-indazole scaffold was developed as an alternate scaffold for our receptor tyrosine kinase (RTK) inhibitor program. In exploring the SAR of this series, it was discovered that a subset of these compounds potently inhibit the enzyme c-ABL. The SAR of these compounds is described.